Qingbi Zhang

Prof. Qingbi Zhang


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2025 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
HWHailan Wang
Hailan Wang
HXHaibo Xia
Haibo Xia
JBJun Bai
Jun Bai
ZWZhongyue Wang
Zhongyue Wang
YWYue Wang
Yue Wang
Qizhan LiuQizhan Liu
Qizhan Liu

1 September 2021 in Toxicology Letters
Verified
Journal Article
Closed access
JBJun Bai
Jun Bai
JDJianjun Deng
Jianjun Deng
ZHZhixia Han
Zhixia Han
YCYan Cui
Yan Cui
RHRenjiang He
Renjiang He
QZQingbi Zhang
Qingbi Zhang

18 June 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HWHong Wu
Hong Wu
XQXiaowei Qi
Xiaowei Qi
GYGuang-Ning Yan
Guang-Ning Yan
QZQingbi Zhang
Qingbi Zhang
CXChuan Xu
Chuan Xu
XBXiu-Wu Bian
Xiu-Wu Bian
The clinical and prognostic significance of CD133 in non-small-cell lung cancer (NSCLC) remains controversial. To clarify a precise determinant of the clinical significance of CD133, we conducted a systematic review and meta-analysis to evaluate the association of CD133 with prognosis and clinicopathological features of NSCLC patients. The electronic and manual searches were performed through the database of Pubmed, Medline, Web of Science, Scopus, and Chinese CNKI (from January 1, 1982 to January 1, 2014) for titles and abstracts by using the following keywords: “CD133”, “ac133” or “Prominin-1”, and “lung cancer” to identify the studies eligible for our analysis. Meta-analysis was performed by using Review Manager 5.0 and the outcomes included the overall survival and various clinicopathological features. A total of 23 studies were finally included, and our results showed that CD133 level was significantly correlated with the overall survival (OR = 2.25, 95% CI: 1.24–4.07, P = 0.008) of NSCLC patients but not with the disease free survival (OR = 1.33, 95% CI = 0.77–2.30, P = 0.31). With respect to clinicopathological features, CD133 level was positively correlated with lymph node metastasis (OR = 1.99, 95%CI = 1.06–3.74, P = 0.03), but not correlated with the histological classification (OR = 1.00, 95%CI = 0.81–1.23, P = 0.99(ac), OR = 0.87, 95%CI = 0.61–1.24, P = 0.45(sc)), or differentiation (OR = 0.94, 95%CI 0.53–1.68, Z = 0.20, P = 0.84 random-effect) of NSCLC patients. High level of CD133 expression trends to correlate with a worse prognosis and a higher rate of lymph node metastasis in NSCLC patients, revealing CD133 as a potential pathological prognostic marker for NSCLC patients.

15 February 2020 in Environmental Toxicology
Verified
Journal Article
Closed access
PDF file
LGLihong Gu
Lihong Gu
SLShangchun Li
Shangchun Li
JBJun Bai
Jun Bai
QZQingbi Zhang
Qingbi Zhang
ZHZhixia Han
Zhixia Han

29 September 2017 in Environmental Science and Pollution Research
Verified
Journal Article
Closed access
PDF file
QYQianlei Yang
Qianlei Yang
YCYan Cui
Yan Cui
FLFei Luo
Fei Luo
XLXinlu Liu
Xinlu Liu
QWQiushi Wang
Qiushi Wang
QZQingbi Zhang
Qingbi Zhang

15 December 2023 in Science of The Total Environment
Verified
Journal Article
Closed access
SLShang-Chun Li
Shang-Chun Li
LGLi-Hong Gu
Li-Hong Gu
YWYan-Fang Wang
Yan-Fang Wang
LWLi-Mei Wang
Li-Mei Wang
Liang ChenLiang Chen
Liang Chen
QZQingbi Zhang
Qingbi Zhang